Cantitate/Preț
Produs

Artificial Intelligence in Drug Design: Methods in Molecular Biology, cartea 2390

Editat de Alexander Heifetz
en Limba Engleză Paperback – 5 noi 2022
This volume looks at applications of artificial intelligence (AI), machine learning (ML), and deep learning (DL) in drug design. The chapters in this book describe how AI/ML/DL approaches can be applied to accelerate and revolutionize traditional drug design approaches such as:  structure- and ligand-based, augmented and multi-objective de novo drug design, SAR and big data analysis, prediction of binding/activity, ADMET, pharmacokinetics and drug-target residence time, precision medicine and selection of favorable chemical synthetic routes. How broadly are these approaches applied and where do they maximally impact productivity today and potentially in the near future. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary software and tools, step-by-step, readily reproducible modeling protocols, and tips on troubleshooting and avoiding known pitfalls. 

Cutting-edge and unique, Artificial Intelligence in Drug Design is a valuable resource for structural and molecular biologists, computational and medicinal chemists, pharmacologists and drug designers.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 115414 lei  43-57 zile
  Springer Us – 5 noi 2022 115414 lei  43-57 zile
Hardback (1) 159305 lei  43-57 zile
  Springer Us – 4 noi 2021 159305 lei  43-57 zile

Din seria Methods in Molecular Biology

Preț: 115414 lei

Preț vechi: 121488 lei
-5% Nou

Puncte Express: 1731

Preț estimativ în valută:
22088 22944$ 18347£

Carte tipărită la comandă

Livrare economică 03-17 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781071617892
ISBN-10: 1071617893
Pagini: 529
Ilustrații: XI, 529 p. 103 illus., 89 illus. in color.
Dimensiuni: 178 x 254 mm
Greutate: 0.93 kg
Ediția:1st ed. 2022
Editura: Springer Us
Colecția Humana
Seria Methods in Molecular Biology

Locul publicării:New York, NY, United States

Cuprins

Applications of Artificial Intelligence in Drug Design: Opportunities and Challenges.- Machine Learning Applied to the Modeling of Pharmacological and ADMET Endpoints.- Fighting COVID-19 with Artificial Intelligence.- Application of Artificial Intelligence and Machine Learning in Drug Discovery.- Deep Learning and Computational Chemistry.- Has Drug Design Augmented by Artificial Intelligence Become a Reality?.- Network Driven Drug Discovery.- Predicting Residence Time of GPCR Ligands with Machine Learning.- De Novo Molecular Design with Chemical Language Models.- Deep Neural Networks for QSAR.- Deep Learning in Structure-Based Drug Design.- Deep Learning Applied to Ligand-Based De Novo Drug Design.- Ultra-High Throughput Protein-Ligand Docking with Deep Learning.- Artificial Intelligence and Quantum Computing as the Next Pharma Disruptors.- Artificial Intelligence in Compound Design.- Artificial Intelligence, Machine Learning, and Deep Learning in Real Life Drug Design Cases.- Artificial Intelligence-Enabled De Novo Design of Novel Compounds that are Synthesizable.- Machine Learning from Omics Data.- Deep Learning in Therapeutic Antibody Development.- Machine Learning for In Silico ADMET Prediction.- Opportunities and Considerations in the Application of Artificial Intelligence to Pharmacokinetic Prediction.- Artificial Intelligence in Drug Safety and Metabolism.- Molecule Ideation Using Matched Molecular Pairs.

Textul de pe ultima copertă

This volume looks at applications of artificial intelligence (AI), machine learning (ML), and deep learning (DL) in drug design. The chapters in this book describe how AI/ML/DL approaches can be applied to accelerate and revolutionize traditional drug design approaches such as:  structure- and ligand-based, augmented and multi-objective de novo drug design, SAR and big data analysis, prediction of binding/activity, ADMET, pharmacokinetics and drug-target residence time, precision medicine and selection of favorable chemical synthetic routes. How broadly are these approaches applied and where do they maximally impact productivity today and potentially in the near future. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary software and tools, step-by-step, readily reproducible modeling protocols, and tips on troubleshooting and avoiding known pitfalls. 

Cutting-edge and unique, Artificial Intelligence in Drug Design is a valuable resource for structural and molecular biologists, computational and medicinal chemists, pharmacologists and drug designers.

Caracteristici

Includes cutting-edge techniques Provides step-by-step detail essential for reproducible results Contains key implementation advice from the experts